Samuel Moed - Jan 1, 2023 Form 3 Insider Report for BiondVax Pharmaceuticals Ltd. (BVXV)

Role
Director
Signature
/s/ Samuel Moed
Stock symbol
BVXV
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/5/2023, 11:48 AM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BVXV Stock Options (right to buy) Jan 1, 2023 Ordinary Shares 720K $0.18 Direct F1, F2
holding BVXV Stock Options (right to buy) Jan 1, 2023 Ordinary Shares 3.28M $0.17 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options were granted on March 24, 2020 and are fully vested.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents four hundred Ordinary Shares.
F3 Stock options were granted on September 2, 2020 and vest on a quarterly basis for a period of three years.